secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tenaya Therapeutics, Inc. (TNYA)
CIK:        0001858848
Form:       8-K
Filed at:   2023-03-21T23:59:59+00:00
Accession:  0000950170-23-008934
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tenaya Therapeutics adopts amended bylaws with enhanced stockholder nomination procedures
--------------------------------------------------------------------------------

- Enhanced disclosure requirements for stockholder director nominations and business proposals.
- Updated provisions to address universal proxy rules and conform to Delaware General Corporation Law amendments.
- Revised procedures for stockholder meetings, quorum, and adjourned meetings.
- Clarified exclusive forum provisions and updated director, committee, and officer sections.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1858848/000095017023008934/0000950170-23-008934-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1858848/000095017023008934/tnya-20230316.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-008934

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer